Cargando…
The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis
BACKGROUND: Adjuvant bisphosphonates reduce the rate of breast cancer recurrence in the bone and improve breast cancer survival. However, the risk of adverse events associated with bisphosphonate therapy for breast cancer remains poorly defined. METHODS: A literature search was conducted using the P...
Autores principales: | Yang, Yan-Li, Xiang, Zi-Jian, Yang, Jing-Hua, Wang, Wen-Jie, Xiang, Ruo-Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558551/ https://www.ncbi.nlm.nih.gov/pubmed/31217825 http://dx.doi.org/10.1177/1758835919855235 |
Ejemplares similares
-
Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK-positive NSCLC
por: Zhu, Qian, et al.
Publicado: (2017) -
Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis
por: Xu, Wentao, et al.
Publicado: (2023) -
Accuracy of ultrasound elastography for predicting breast cancer response to neoadjuvant chemotherapy: A systematic review and meta-analysis
por: Chen, Wei, et al.
Publicado: (2022) -
Efficacy and safety of bisphosphonates on childhood osteoporosis
secondary to chronic illness or its treatment: a meta-analysis
por: Zhao, Huawei, et al.
Publicado: (2022) -
Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis
por: Pei, Wen-Guang, et al.
Publicado: (2023)